Pharmafile Logo
Pharmafocus logo
Advanced Search

HPV vaccine to be given to boys in England

July 25, 2018
Research and Development Cancer, HPV, infectious disease, sexually transmitted diseases, vaccines, virus

The government has announced that boys in England aged 12 and 13 will be vaccinated against Human Papilloma Virus (HPV) …

News

Pfizer to build $465m sterile injectable plant in Michigan

July 25, 2018
Manufacturing and Production, Research and Development Michigan, Pfizer, US, manufacturing, pharma

Pfizer has unveiled plans to invest $465 million to build a new sterile injectables plant in Portage, Michigan, saying that …

News

More antidepressants being prescribed to children in UK

July 25, 2018
Research and Development antidepressants, children, mental health, prescription, young people

Figures have revealed a trend towards an increased number of prescriptions for antidepressants for children in England, Scotland, and Northern …

News

Eleven babies dead after Dutch viagra trial

July 25, 2018
Research and Development Netherlands, clinical trial, deaths, premature, viagra

A trial of the drug sildenafil, commonly sold under the brand name Viagra, has been halted immediately after the death …

News
stana-moisescu-appointment

Teva Romania announces new general manager

July 24, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Israeli multinational Teva Pharmaceuticals have announced the appointment of Stana Moisescu as the General Director of Teva Romania, the company’s …

Appointment
murdo_gordon-bio

Bristol Myers Squibb announces departure of Chief Commercial Officer

July 24, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, bristol myers squibb, commerical executive, marketing, sales

Bristol Myers Squibb has announced that Executive Vice President and Chief Commercial Officer, Murdo Gordon, who has been with the …

Appointment
celgene_building

Celgene’s Revlimid combo meets Phase 3 goal in relapsed/refractory indolent lymphoma

July 24, 2018
Manufacturing and Production, Research and Development Celgene, Revlimid, lymphoma, pharma

Celgene has lifted the curtain on new Phase 3 data for its combo of Revlimid (lenalidomide) plus rituximab (R2) in …

News
25870220061_456a80df07_z

Employees protest against shutting down of GSK facility in Bangladesh

July 24, 2018
Manufacturing and Production Bangladesh, GSK, manufacturing, protest, union

Employees of the British multinational GlaxoSmithKline (GSK) have led a protest against the shutting down of manufacturing facilities in Bangladesh. …

News

Scientists launch free, open access, antibiotics database to tackle AMR

July 24, 2018
Manufacturing and Production AMR, Antibiotics, Database, academia, resistance

A team of scientists, led by Professor Laura Piddock from the University of Birmingham, have launched a free, open access, …

News
astrazeneca_plaque

AstraZeneca jettisons European heart drug rights for $210m

July 24, 2018
Manufacturing and Production, Sales and Marketing AstraZeneca, Atacand, Cheplapharm, blood pressure, heart failure, pharma

AstraZeneca has announced its intention to hand over the European commercial rights to its heart failure and blood pressure treatment …

News
mosquito-1016254_1280

First new treatment for reccurent malaria approved in over 60 years

July 23, 2018
Manufacturing and Production FDA, GSK, approval, malaria, p.vivax

The FDA has approved GSK’s Krintafel for the treatment of a recurring form of malaria in patients aged 16 and …

News
512px-antibiotic_sensitvity_and_resistance

The mission against antimicrobial resistance

July 23, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance, antimicrobial resistance, feature, pharma

Two headlines have highlighted the ‘here and now’ of the threat of rising antimicrobial resistance (AMR), writes Dr Peter Jackson.A …

Feature

FDA approves Agios’ oral leukaemia treatment Tibsovo

July 23, 2018
Sales and Marketing FDA, agios, approval, pharmaceuticals, tibsovo

The oral leukaemia treatment Tibsovo (ivosidenib) produced by Massachusetts-based Agios Pharmaceuticals has been approved for treatment of adult patients with …

News
allergan

US court overturns Allergan’s controversial attempts to avoid Restasis patent review

July 23, 2018
Sales and Marketing Allergan, Mylan, Restasis, US, dry eye, pharma

The US Court of Appeals for the Federal Circuit has seen fit to authorise a US Patent and Trademark Office …

News
roche_dark_0

Roche join Pfizer and others in price freeze while critics pose questions

July 23, 2018
Sales and Marketing Donald Trump, Roche, generics, price freezes

Swiss multinational Roche has joined Pfizer and others in halting price hikes. However critics have condemned the move as observers …

News
fda2outsideweb

FDA approves Pfizer biosimilar version of Amgen’s Neupogen

July 23, 2018
Sales and Marketing Amgen, FDA, Neupogen, Nivestym, Pfizer, pharma

The FDA has announced its decision to approve Pfizer’s Nivestym, the firm’s biosimilar version of Amgen’s Neupogen (filgrastim), for use …

News
li_keqiang_chinese_and_foreign_press_conference

Chinese premier slams drug maker after vaccine scandal

July 23, 2018
Sales and Marketing CCP, China, biotech, scandal, vaccines

Chinese Premier Li Keqiang has spoken out against drug maker Changsheng Biotechnology after the Chinese firm was found to have …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

July 20, 2018
Medical Communications GSK, ICR, J&J, JJ, Novartis, Trump, brexit, top 10

As Brexit negotions have hit a stalemate this week, the United Kingdom’s exit from the European Union has hit the …

News
ki67-tubulin-2

Scottish borders-based Ryboquinn acquires viral delivery comany Nanogenics

July 20, 2018
Medical Communications M&A, MA, Scotland, acquisitions, gene therapy, nanogenics, ryboquinn

The Scottish biotech company Ryboquinn has acquired English partner Nanogenics Solutions in a deal worth £4.45 million. The Selkirk-based firm …

News
16792957331_d9572dbdf4_z

FDA explores import strategy in effort to reduce price of drugs

July 20, 2018
Medical Communications Drug pricing, Trump, borders, import, the donald

The FDA has been directed to explore ways in which medicines could be safely imported from other countries “in the …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026